Therefore, in the present study, we conducted a retrospective analysis of clinicopathological data of breast cancer patients, to explore the relationships between preoperative serum CEA, CA15-3 levels and clinicopathological parameters, as well as the prognostic value of these two serum biomarkers in breast cancer. The gene discussed is CEACAM5; the disease is breast carcinoma.